DIA
CTIC

Denver Investment Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Denver Investment Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,299
Closed -$114K – 665
2015
Q1 		$114K Sell
6,299
-133
-2% -$2.99K ﹤0.01% 612
2014
Q4 		$152K Buy
6,432
+27
+0.4% +$624 ﹤0.01% 589
2014
Q3 		$155K Buy
6,405
+361
+6% +$9.38K 0.01% 566
2014
Q2 		$170K Buy
+6,044
New +$182K 0.01% 568

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Denver Investment Advisors's CTIC Position: Q2 2015 in Review

Denver Investment Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2015, closing a stake of 6,299 shares — an estimated $114K sold.

Denver Investment Advisors first reported a position in CTIC in Q2 2014 and held it in 4 quarters. The position peaked at $170K in Q2 2014. 95 funds tracked by Wall St. Rank hold CTIC as of Q2 2015.

  • Denver Investment Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 6,299 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2015, an estimated $114K.
  • Denver Investment Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2014 and held it in 4 quarters.
  • Denver Investment Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $170K in Q2 2014.
  • 95 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.